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Implications 
Practice: A combination of motivational counselling and short messages targeting 
alcohol intake, tobacco smoking and treatment adherence delivered by lay 
counsellors, is a feasible intervention that may improve tuberculosis treatment 
outcomes. Ongoing monitoring of intervention fidelity and training of counsellors is 
essential.  
Policy: If the proposed intervention proves to be effective in a larger trial, 
policymakers should aim to build tobacco cessation and alcohol reduction strategies 
into TB control programmes. 
Research: Future research should be aimed at determining the effectiveness and 
cost-effectiveness of the proposed intervention in a large randomised controlled trial. 
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Addressing tobacco smoking and drinking to improve TB 
treatment outcomes, in South Africa: a feasibility study of 
the ProLife programme 
Abstract  
Background: Alcohol and tobacco use may lead to negative treatment outcomes in 
tuberculosis (TB) patients, and even more so if they are HIV-infected. We developed 
and tested the feasibility of a complex behavioural intervention (ProLife) delivered by 
lay health workers (LHWs) to improve treatment outcomes in TB patients who smoke 
tobacco and/or drink alcohol, at nine clinics in South Africa. Methods: The 
intervention comprised three brief motivational interviewing (MI) sessions augmented 
with a Short-Message Service (SMS) programme, targeting as appropriate: tobacco 
smoking, harmful or hazardous drinking and medication adherence. Patients 
received SMS-messages twice a week. We measured recruitment and retention 
rates and assessed fidelity to the MI technique (MI Treatment Integrity 4.1 tool). 
Lastly, we explored LHWs’ and patients’ experiences through interviews and semi-
structured questionnaires, respectively. Results: We screened 137 TB patients and 
identified 14 smokers, 13 alcohol drinkers and 18 patients with both behaviours. 
Participants’ mean age was 39.8 years, and 82.2% were men. The fidelity 
assessments pointed to the LHWs’ successful application of key MI skills, but failure 
to reach MI competency thresholds. Nevertheless, most patients rated the MI 
sessions as helpful, ascribed positive attributes to their counsellors, and reported 
behavioural changes. SMS-messages were perceived as reinforcing but difficult 
language and technical delivery problems were identified as problems. The LHWs’ 
interview responses suggested that they (a) grasped the basic MI spirit but failed to 
understand specific MI techniques due to insufficient training practice; (b) perceived 
ProLife as having benefitted the patients (as well as themselves); (c) viewed the SMS 
messages favourably; but (d) considered limited space and privacy at the clinics as 
key challenges. Conclusions: The ProLife programme targeting multiple risk 
behaviours in TB patients is acceptable but LHW training protocol, and changes in 
wording and delivery of SMS messaging are necessary to improve the intervention.  
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Background 
South Africa has the highest tuberculosis (TB) incidence rate out of 30 high TB-
burden countries in the world [1]. Successful TB treatment is compromised by high 
rates of treatment interruption, drug resistance and deaths [1]. TB patients who are 
HIV-positive are at greater risk of dying, but early antiretroviral treatment (ART) 
initiation greatly reduces this risk [2]. Successful TB treatment can also be 
compromised by lifestyle behaviours. In particular tobacco use and problem drinking 
are common among TB patients [3-5]. Both smoking and alcohol use increase the 
risk of death and poor treatment adherence for TB patients [6, 7]. Tuberculosis 
patients who smoke tobacco have treatment failure more often and are prone to 
relapse [8]. Furthermore, patients who are co-infected with TB and HIV, and who 
smoke, are predisposed to many HIV-related complications [9]. In addition tobacco 
smoking and alcohol consumption are associated with reduced ART initiation and 
adherence [10, 11], which also negatively influences clinical response to treatment. 
There is thus a need to address smoking and drinking in patients with TB and HIV 
co-infection. 
Brief smoking cessation interventions are effective and affordable in low-income 
countries, both for TB patients and other smokers [12-14]. Disease diagnosis can 
constitute a ‘teachable moment’, therefore TB patients are more likely to be receptive 
to interventions and more likely to succeed in quitting smoking and moderating 
alcohol use, compared to general smokers and problem drinkers [15]. Due to the 
widespread comorbidity of TB with communicable and non-communicable diseases, 
scientists have advocated that TB control efforts integrate with general health care 
services [16, 17], which include treatment for addiction. Addressing smoking and 
alcohol misuse in TB patients can have clear short- and medium-term benefits [9, 
18]. TB patients who stop smoking show a reversal of immunological abnormalities 
within six weeks of cessation and could have a greatly reduced risk of death due to 
TB. Although many studies have separately evaluated the effectiveness of tobacco 
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cessation, alcohol reduction or adherence interventions in TB patients [19, 20], only a 
few have considered joint interventions for multiple behaviours to improve treatment 
outcomes [21, 22] even though these behaviours often co-exist in the same patients 
[4, 5]. 
To our knowledge, no studies have reported on interventions that use Motivational 
Interviewing (MI), a patient-centred counselling approach, to address multiple 
behavioural problems that negatively impact TB outcomes. Motivational interviewing 
is a counselling style that helps patients to explore and resolve ambivalence aimed at 
changing behaviour [23]. This counselling technique has been used effectively to 
reduce hazardous drinking, effect tobacco cessation, and improve TB treatment or 
ART adherence [13, 24-26]. Motivational interviewing can be adapted for use in busy 
clinical practices [27] and even single session interventions have been successfully 
used by lay health workers (LHWs) to effect behaviour change [13]. Mobile phone 
technology using SMS messages can also enhance ART adherence and smoking 
cessation interventions [28, 29] and potentially promote adherence to TB treatment 
[30].  
Given the potential benefits of MI and SMS-messages to reduce smoking and alcohol 
use by TB patients, we designed the ProLife programme. This programme aims to 
improve TB treatment outcomes by modifying life-style behaviours through a brief 
motivational intervention and SMS-programme. We tested the feasibility of this 
programme in a group of TB patients that used tobacco, drank alcohol or did both, by 
(a) monitoring fidelity to MI sessions and assessing the proficiency of LHWs in 
facilitating the MI sessions; (b) evaluating the experiences of TB patients and LHWs 
with the interventions; and (c) determining enrolment and follow-up rates of TB 
patients in the study.  
Methods 
Design 
We used the United Kingdom Medical Research Council guidelines for developing 
and evaluating a complex intervention as a guide [31]. First we developed a 
conceptual framework based on existing evidence of behavioural factors that 
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influence TB treatment outcomes (Figure 1). We then used mixed methods -
described in the methods section- to determine the intervention fidelity, acceptability 
and likely enrolment and retention rates of the future trial.  
 
 
 
 
 
Figure 1: Conceptual framework of the ProLife programme to reduce smoking 
and alcohol consumption in TB patients and potential impact on TB treatment 
outcomes. 
 
Study setting 
This study was conducted in one health district in each of three South African 
provinces (Free State, Gauteng and North West), in three clinics per district. 
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Study participants 
Participants were adults who were due to start TB treatment, or who had been on 
treatment for less than one month for the current TB episode for bacteriologically or 
clinically confirmed drug sensitive pulmonary TB (PTB) [32]. Eligible patients included 
current smokers, defined as having smoked any tobacco in the past month, and 
hazardous or harmful drinkers. We identified hazardous drinkers according to the 
Alcohol Use Disorders Identification Test [AUDIT] score ≥ 8 for men or ≥ 7 for women 
and < 16 for hazardous drinking and between 16 and 19 for harmful drinking [33]. 
Patients who smoked and drank alcohol were also enrolled. We did not enrol 
dependent drinkers, defined as those with an AUDIT score > 19, but referred them 
for specialist treatment and intensive intervention. However, we retained patients 
who were both alcohol dependent (AUDIT >19) and smoked because their smoking 
could be amenable to the MI intervention. These participants received the smoking 
cessation intervention for their tobacco smoking but specialist referral for their alcohol 
problems. We excluded patients who did not possess a functioning cell phone, were 
too ill to be interviewed or did not speak any of the languages used in the exit 
questionnaires (English, Isizulu, Sesotho and Setswana). 
To measure fidelity to the MI counselling intervention, we randomly sampled one 
patient enrolled between 15 November 2016 and 30 February 2017 for each LHW. 
Random selection was chosen to reduce bias introduced by knowledge of being 
observed. If a selected patient did not have three recordings of counselling sessions, 
we selected the next available patient.  
Lay health workers delivered the intervention and also participated in exit interviews. 
The criteria used to select LHWs are described in the next section.  
The ProLife intervention programme package 
Motivational Interviewing (MI) 
Motivational Interviewing is an approach in which the counsellor helps the client to 
explore motivation and confidence to change harmful behaviours and, to identify 
suitable ways to deal with obstacles to behaviour change [23]. The five guiding 
principles of MI are (a) expressing empathy, (b) developing discrepancy, (c) avoiding 
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argumentation, (d) rolling with resistance, and (e) supporting self-efficacy [34]. We 
opted for a brief MI approach [27] as the programme had to be feasible in the 
resource constrained environments of busy TB clinics in South Africa, and other low 
and middle-income countries. The recommended duration of an MI session was 20 
minutes. 
Eligible LHWs had completed high school and completed the nationally prescribed 56 
days training for community health workers, which included a large section on HIV 
and TB treatment and care. Eligible CHWs also had at least one year of previous 
relevant HIV- or TB-related counselling experience. Until recently different categories 
of LHWs were employed in the South African public health services. They fulfilled –
amongst others- roles as lay HIV counsellors and TB treatment support workers. The 
South African Department of Health is currently integrating the different LHW cadres 
into one single cadre. For this study we recruited nine LHWs who had not or not yet 
been absorbed into the new LHW body [35]. 
During an expert review workshop, we compiled background information on tobacco 
cessation, problem drinking and factors that influence adherence, and agreed on the 
framework of the MI counselling intervention. An experienced, certified MI facilitator 
then developed a detailed training manual in collaboration with the experts and 
trained the LHWs in a five day workshop. In the first intervention session - at the start 
of TB treatment - LHWs established rapport and determined the participant’s tobacco 
smoking, problem drinking and other potential obstacles and facilitators for treatment 
adherence. With the support of the LHW the patient then identified his/her priority 
problem for change (namely alcohol, tobacco or medication adherence), thus setting 
the agenda for change. This agenda for change could include a plan to quit tobacco 
smoking, reduce drinking or deal with other perceived obstacles relating to treatment 
adherence or initiation. The LHW also informed the patient about the nature and 
frequency of the upcoming SMS messages. The second MI session built on the 
previous session, dealt with challenges relating to the previously set agenda, and 
then proceeded to the next behavioural problem. The third session either dealt with 
the final identified problem or reinforced the previous message. The one-to-one 
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counselling sessions were reinforced by SMS-messages, supporting tobacco 
cessation, alcohol use and medication adherence.  
SMS-programme 
The tobacco cessation and TB-related messages were selected and adapted from an 
SMS-bank developed by the World Health Organisation as part of their “Be He@lthy 
Be Mobile programme” [36]. The research team developed the alcohol-related 
messages during an expert workshop. We based the content of the SMS-messages 
on the Information-Motivation-Behavioural Skills programme as adapted for TB [37, 
38]. For example, to target smoking cessation, we sent the message “Within 1 month 
of quitting, you will cough less and breathe easily” to provide information and 
motivate the participant to quit. TB-related messages also included some messages 
that were not directly related to TB medication-adherence but to infection risks, as 
they may motivate participants to take their treatment to protect family members. The 
complete set of messages is presented in Table 1. Professional translators translated 
the SMS-messages into the three most common local languages and we formatted 
the messages to comply with SMS character limitations. Study patients received 10 
TB-related messages followed by seven alcohol reduction- and/or seven smoking 
cessation-related messages, as appropriate. The SMS-stream was automatically 
system-generated one day after the first MI session and was delivered twice a week 
for up to 12 weeks (Figure 2). It was technically not feasible for our SMS service 
provider to tailor the SMS text message order to match the order of the individual 
patient’s MI sessions. 
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Figure 2. Delivery of the ProLife intervention to stop smoking and reduce the 
consumption of alcohol in newly diagnosed TB patients. 
 
Measurements and data collection 
Between 15 November 2016 and 30 March 2017, fieldworkers identified eligible TB 
patients at respective TB clinics, using a screening questionnaire, and scheduled 
three MI sessions: at enrolment, at one month and at two months. Attempts were 
made to schedule the MI counselling appointments on the same day as patients’ TB 
treatment appointments. Patients received SMS-reminders of planned and missed 
visits. District study coordinators and fieldworkers (not involved with MI counselling) 
contacted patients who missed planned visits. The MI sessions were audio-recorded 
- with participant permission - for later assessment of treatment fidelity. 
After patients’ third MI session, district study coordinators interviewed them using a 
semi-structured questionnaire in their preferred language, to determine their 
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experiences with the counselling, the counsellors and the SMS-programme. The 
patient questionnaire was developed specifically for this study and consisted of 
structured questions with binary or Likert-type response options and a few open 
questions.  
Each LHW was interviewed by a trained Master’s degree student (LP), using an 
open-ended question format after they had completed counselling sessions with at 
least three TB patients, where possible. The interview topics included: LHWs’ 
experiences with MI delivery, their perceptions regarding the SMS-programme, the 
perceived impacts of MI on the patients, and their overall experiences with the 
ProLife project. The interviews were audio-recorded and translated into English. 
Data management and analysis 
Quantitative data from the semi-structured questionnaires with TB patients were 
analysed with Stata Statistical package version 14 [39]. Data were descriptively 
analysed with percentages, means and standard deviation or medians and 
interquartile ranges, as appropriate.  
Qualitative data from the exit interviews with LHWs were transcribed. They were then 
thematically analysed using a deductive “top down” approach [40] owing to the need 
to answer specific questions related to the feasibility and acceptability of the 
intervention based on the LHWs’ (as intervention deliverers) impressions. We took 
the following steps in analysing the data: familiarization with the data by reading and 
re-reading the transcripts, generation of codes, development of themes, and 
reviewing and refining themes [40]. Two researchers independently identified the 
themes and compared results until the final sets of themes were incorporated. From 
the vast amount of qualitative data obtained and analysed, we present the findings 
that are most pertinent to the questions of the intervention’s feasibility and 
acceptability [41] and that can highlight changes that would be needed to the 
intervention in the main trial.   
Counselling sessions were audio-recorded, transcribed, translated and coded 
independently by two researchers. To assess MI fidelity, coders listened directly to 
the audio-recordings in the original language and read through the transcribed and 
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translated transcripts. The fidelity of the MI intervention was determined with the MI 
Treatment Integrity tool version 4.1 [42, 43]. This tool consists of two components viz. 
“global ratings” and “behaviour counts”. The “global ratings” allow the coder to 
assess, on a 5-point Likert scale (1 for low and 5 for high), how well or poorly the 
counsellor adheres to the MI practice. Ratings are conducted on four items, divided 
into Technical Components (Cultivating change talk and Softening sustain talk) and 
Relational Components (Partnership and Empathy). Scores on Cultivating Change 
Talk and Softening Sustain Talk are averaged to obtain the Technical global scores 
while scores on Partnership and Empathy are averaged to obtain Relational global 
scores. The basic competency threshold scores for Technical and Relational scores 
are 3 and 3.5, respectively. The “behaviour counts” involve counting 10 verbal 
behaviours of the counsellor during the intervention: Giving Information, Persuade, 
Persuade with permission, Asking questions, Simple reflections, Complex reflections, 
Affirm, Seeking collaboration, Emphasizing autonomy and Confront. Counts involve 
simply adding the number of statements that fall in a certain category. “MI adherence” 
is determined by adding up the following verbal behaviours: Seeking Collaboration, 
Affirm and Emphasizing autonomy. “MI non-adherence” is determined by summing 
instances of Confront and Persuade. No thresholds for MI adherence or non-
adherence are specified in the MITI 4.1 manual [43]. The Reflection-to-Question 
(R:Q) ratio and Percentage of Complex Reflections (% CRs) are also determined. 
One reflection to each question is considered a “fair” practice level while two 
reflections to each question is considered a “good” practice level. A fair and a good 
% CRs are 40% and 50%, respectively. Individual and summary scores were 
calculated for each coder as well as for both coders together. The intra-class 
correlation, using the two-way mixed model with absolute agreement, was used as a 
measure of interrater reliability for the summary measures. 
Ethical considerations 
Ethics clearance was obtained from the Ethics committees of Sefako Makgatho 
Health Sciences University (SMUREC/D/77/2016:IR) and from the other five 
participating research institutions. Informed consent was obtained from all individual 
participants (both TB patients and LHWs). TB patients received ZAR 60 (about 4 
USD) reimbursement for each study visit. The Prolife study was registered in the 
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ISRCTN registry with study ID ISRCTN62728852. Participants with serious social or 
mental health problems were referred to a social worker, clinical psychologist or 
psychiatric care; whichever was available. 
Results  
Enrolment and follow-up of study patients  
Enrolment and follow-up figures are presented in Figure 3. Out of 141 TB patients 
approached to participate in the study, 137 consented to screening, of which 92 were 
excluded for reasons listed in Figure 3. The most common reason for exclusion was 
having already been on TB treatment for more than one month. Only 21 patients 
were excluded because they did not smoke cigarettes or drink alcohol to excess. 
Eventually 45 patients were enrolled. 
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Figure 3. Screening, enrolment and follow-up of patients with TB who smoked 
cigarettes or drank alcohol.  
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aThree patients were enrolled in cell phone test mode and their data could not be fully recovered. They also 
received incomplete SMS-messages. They were excluded from the study; TB Rx > 1/12: TB treatment for greater 
than one month; LTFU: Loss to follow-up. 
 
 
Patients were on average 39.8 years old (SD 13.3) and most were male (82.2%). 
Nearly one third of the patients were eligible because of exclusively drinking (28.9%), 
31.1% because of exclusively smoking and 40.0% for concurrently drinking and 
smoking. Nearly all patients (93.3%) received their first MI counselling session, but 
close to 30% failed to receive their second or third MI session due to various reasons 
(Fig 3). Two patients died due to causes that were unrelated to the study: one 
between baseline and one month follow-up and one between one and two months 
follow-up (Fig 3).  
Motivational interviewing fidelity 
We analysed the fidelity of 22 MI sessions (out of a target number of 27 sessions). 
Two recordings (one for two different LHWs each) were not audible, for two sessions 
the patient declined permission to record, and one recording could not be retrieved. 
The random selection of one patient per LHW for the fidelity assessments led to 
selection of the first patient to be counselled in the case of two LHWs; the second 
patient for three LHWs; and the third patient for four LHWs. The recorded sessions 
lasted from 5–26 minutes (Mean = 18 minutes; SD = 5.8). The MITI tool recommends 
that a section of 20 minutes is analysed to determine the fidelity. Where the session 
was shorter than 20 minutes, the entire session was analysed. 
In terms of the global ratings (see Table 2), the LHWs’ counselling sessions were 
generally below proficiency levels on Cultivating Change Talk and Partnership 
(defined as mean score below 2). Scores were however better for Softening Sustain 
Talk. The LHWs’ counselling sessions did not achieve the basic proficiency threshold 
of 3.5 for the Relational component (Partnership + Empathy). Their mean score on 
the Technical component (Cultivating Change Talk + Softening Sustain Talk) was 
also below the threshold of 3 for both coders. However, the interquartile ranges 
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(IQRs) of the global rates suggest wide variation in the quality of the MI sessions with 
the upper quarter of the IQR reaching close to proficiency levels (Table 2). 
For behavioural counts, “Asking Questions” had the highest mean score (more than 
16) for both coders, followed by “Simple Reflection” with an average mean score of 
4.9. The counsellors did not perform well on the following domains: Giving 
Information, Complex Reflections and Seeking Collaboration (Table 2). The overall % 
Complex Reflections threshold of 40% was not reached. The mean Reflections to 
questions ratio was 0.4, which did not meet the fair or good competency and 
proficiency ratios of 1:1 and 2:1, respectively. The LHWs made on average 5.5 MI 
adherent (Affirm, Emphasize Autonomy and Seek Collaboration) and 3.3 non-
adherent (Confront and Persuade) statements. 
Other problems that were identified from listening to the recordings were that LHWs 
struggled to set the agenda at the beginning of the sessions and evoke change talk. 
Some of the LHWs dealt with three target goals (smoking, alcohol and medication 
adherence) all at once and were unable to focus and direct the session effectively. 
Furthermore, many LHWs struggled with use of the “ruler” on which patients were 
asked to indicate their motivation and confidence to change, on a 10-point scale.  
The interrater reliability of the two coders over all three sessions was in the excellent 
range for the total number of MI adherent (Intracluster Correlation Coefficient [ICC]: 
0.96) and MI non-adherent behaviors (ICC: 0.97). The interrater reliability was 
moderate for Relational scores (ICC 0.67) and good for Technical scores (ICC 0.82) 
(Table 2).  
TB patients’ experiences with the Prolife intervention: questionnaire results 
We administered the questionnaire to 29 patients, but data were missing for four 
patients for whom electronically captured data did not synchronise at the level of the 
data server and could therefore not be retrieved. As shown in Table 3, most patients 
rated the intervention sessions as “helpful”, “somewhat helpful” or “very helpful”. All 
patients reported enjoying the sessions “quite a lot,” “very much” or “a great deal”. 
About half of the patients reported reduced smoking and drinking. Most patients 
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reported feeling better emotionally and physically and better adherence to TB 
treatment. All patients reported liking the counsellors’ style of interacting “quite a lot”, 
“very much”, “a great deal”, and patients ascribed many positive attributes to the 
counsellors while rarely endorsing any listed negative attributes (Table 3). 
Responses to the open-ended questions supported the trends from the closed 
questions. None of the patients reported challenges with the counsellors. They were 
satisfied overall with the programme and expressed happiness in participating, but 
also mentioned a few shortcomings of the intervention. For example, several patients 
did not like the counselling sessions being recorded. The TB patients’ experience 
with the SMS-messages was also positive overall, as indicated by their responses to 
the exit interview questions shown in Table 4. However, some of them struggled to 
understand some messages, or had technical problems with their phone or with the 
SMS-delivery. For example, some patients received many messages at once or none 
at all. However, most patients indicated that they would have liked to receive 
messages for a longer time period (Table 4).  
LHWs’ experience of the Prolife intervention: themes from interviews  
MI Delivery: The most pertinent themes that were identified from the LHWs’ accounts 
regarding MI delivery were that they had grasped the overall spirit of MI, that they did 
not know how and when to implement some specific MI techniques, and that the MI 
training and opportunities for practicing had been limited. For example, one LHW 
described her experience of the MI approach as follows: 
“The things I was able to do even after training were open-ended 
questions, affirmation, reflecting and making a summary of what the 
client is telling me, but the problem is I could not put them in order.” 
Another common challenge was not knowing how to deal with patients who denied 
using tobacco or alcohol. The LHWs felt positive overall about the training received 
but felt unprepared for the diversity of problems, attitudes and beliefs that patients 
presented with. They felt that they needed additional practice to enable them to more 
confidently implement the MI intervention. The following quote is illustrative:  
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“…everything was done well in the training, because at the training 
it’s simple to answer questions and now when it comes to the 
counseling it’s a challenge because you get different clients depending 
on their problems, so if you practice more it could help, (...)”  
Perceived Impact of the Prolife Programme: The LHWs reported numerous ways in 
which they believed patients benefited from being in the programme. These included 
observing improvements in patients’ general physical and mental health, their TB, 
and also in their knowledge, motivation to change and actual change in drinking and 
tobacco smoking behavior. The following quotes exemplify this observation: 
“The first patient, like he was literally crying, and he explained to me 
that he has difficulty because he lives alone and feels lonely and is 
suicidal, so he felt if the programme gets terminated there won’t be 
anyone who will listen to him. So I think MI has a big impact on 
people’s lives, (…). Like he was happy as if I did something and all I 
did was sit and acknowledge him. (…) so people really need MI 
because there is no one who talks to them at home, (...).”  
SMS Messages: The LHWs’ narratives suggested that they had an overall positive 
view about the SMS-messages. They felt that the SMS-messages complemented the 
ProLife programme in a number of ways, such as by reminding them about the facts 
and information imparted and behavior change(s) agreed upon.  
“According to me I think they (MI and SMS) are both important 
because patients are happy that we talk to them verbally and again 
send SMSs that remind them of the important comments” 
They however felt that the SMS-messages might not be suitable for patients who do 
not own phones or had to rely on others to access their messages.  
Overall Assessment of the ProLife Intervention: The LHWs’ assessments of the 
intervention were overall positive, although they also noted some challenges. They 
were pleased by patients’ apparent appreciation of being in the intervention; an 
impression that stemmed from the LHWs’ observation of patients’ visits to the sites 
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and their attendance at the initial and follow-up counseling sessions; as indicated by 
this LHW’s comments: 
“The things I liked are that the patients were happy. Most of them 
were on time for the session, and they would come when we were 
busy recruiting (…) just to pass their greetings. They would be happy 
just to see that there are people who care and want to see them 
cured and feeling good.” 
The LHWs felt that there is widespread need for a ProLife intervention and they were 
very positive about their experiences in the project as a whole. One LHW described 
her feelings as follows: 
“I like knowing about the new counselling programme. It helped me 
not only to help people who are sick but in life in general, (…). Also 
the fact that I was making a difference in people’s lives, like 
sometimes nurses shout at them (patients) and when they think of 
going back to the clinic to come across the rude nurse again they 
rather stay home, (…).” 
However, the LHWs assessed the limited space and privacy for sessions in the 
clinics as challenging. They were also concerned about the well-being of very ill 
patients and becoming infected with TB in TB clinic settings. They also felt that the 
use of tape recorders hindered free participation by some of the patients. 
Discussion  
This study’s findings are in support of the relevance of addressing smoking and 
drinking in TB patients, in particular in male TB patients. Eighty percent of our study 
participants were male. This male predominance differs from general TB statistics in 
South Africa in which on average only about half of all the TB patients are men [4]. 
Smoking and drinking is therefore particularly prevalent in male TB patients and 
warrants specific attention for counselling on alcohol and tobacco in this patient 
group [13]. Both tobacco smoking and problem drinking were relatively common in 
newly diagnosed TB patients with more than a third of the enrolled patients 
concurrently smoking and drinking alcohol. The clustering of addictive behaviours in 
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our study is consistent with findings in the published literature [44]. Recent evidence 
suggests that multiple risk behaviour interventions similar to the ProLife programme, 
can be effective and that sequentially addressing smoking alongside other 
interventions as used in ProLife is preferable to simultaneous interventions [45].  
Even though MI was positively received, LHWs were not fully confident with using all 
of the specific techniques and tools and did not achieve the desired MI proficiency. 
One of the possible explanations is that thresholds recommended in the MITI 4.2 
guidelines are designed for full-length MI sessions and may not necessarily be 
appropriate for brief MI sessions in which there would naturally be fewer behavioural 
counts and fewer opportunities for reflections. Also, the context in which the MI took 
place, namely at a “teachable moment”, could explain the low change talk counts 
versus the high sustain talk counts. These results may also have arisen because the 
LHWs had not yet acquired much experience in MI counselling: some LHWs applied 
the newly learnt skills for the first time in a real patient setting at the time of the 
selected MI recording. Also, the LHWs often assumed an expert role thus leading to 
low scores for the “partnership” attribute. In struggling to transition their practice from 
more traditional counselling to the MI style, LHWs often provided information without 
asking permission, directed patients on what to do, but seldom let the patients decide 
on what measures they needed to take to achieve the desired change. These 
findings are consistent with those of another South African study which also reported 
low competency of lay counselors in delivering MI despite five days of training [46]. 
Lay health workers require extended practice and follow-up support to ensure that 
they are completely competent in MI delivery [47, 48].  
Although the South African National TB treatment guidelines clearly stipulate the 
need for counselling for TB patients on tobacco smoking and drinking [32], it is not 
clear whether these guidelines have been adhered to or are adopted. Several TB 
patients stated that they felt listened to and “heard” for the first time in the ProLife MI 
counselling sessions. Patients said that the MI sessions motivated them to adhere to 
their TB/HIV treatment and encouraged them to reduce their drinking and smoking. 
Similarly, LHWs, who all had prior training and experience with counselling, reported 
having learnt completely new techniques, such as simple listening or showing 
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empathy, and expressed surprise at their effectiveness as a communication strategy. 
The counselling style adopted in MI differs from the paternalistic styles sometimes 
adopted by lay counsellors in South Africa [46][48]. The positive reception of MI by 
LHWs and patients combined with existing evidence of the effectiveness of MI [13, 
24-26] are encouraging reasons to test this intervention in a definitive trial. For the 
trial that is following this study, we have provided four days additional MI training with 
specific emphasis on shortcomings identified during the feasibility study. Contextual 
challenges, such as lack of space and privacy in clinics, were also addressed.  
Similar to the findings of another study in South Africa [49], patients in this study 
were overall positive about the SMS-messages. The SMS messages served as 
important reminders and motivators to sustain behaviour change. Many patients 
wanted to receive the messages for longer. However, some patients said that 
messages were difficult to understand. We have since revised the translation. In the 
era of information technology, the World Health Organisation has recommended 
digital health as one of the strategies to help end TB, but highlights the need for more 
evidence on its effectiveness [50]. This feasibility study and the planned trial will aid 
in providing answers about the use of the recommended mHealth (mobile health) for 
patient care. 
Our study was limited by the small sample size. Social desirability bias may have led 
to overly positive feedback from both LHWs and TB patients: Self-reported 
reductions in drinking and smoking were not validated. The assessment of randomly 
selected counselling sessions without considering the timing of those sessions may 
have led to an under-estimation of the LHWs’ overall competency. Furthermore the 
sample size was too small to determine within LHW improvement of counselling skills 
over time. The order of delivery of SMS-messages was fixed which may have led to 
poor synchronisation with the contents of the MI-sessions. During implementation, 
the custom-designed software package for enrolment and follow-up of study 
participants linked to the delivery of SMS-messages posed some challenges with 
system design and poor data synchronisation, often due to erratic internet access at 
some study sites. The SMS-delivery system was reviewed, another service provider 
was appointed for the SMS-delivery and a dedicated data manager is closely 
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monitoring the SMS-delivery in the roll-out of the actual trial. The challenges 
identified in this study are not unique [51] and serve as helpful guidance for other 
researchers and policy makers who plan to introduce digital health interventions in 
similar settings.  
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Table 1. SMS-programme message sequence and IMB-content 
MI  
ses
sion 
W
ee
k 
D
ay 
TB disease and treatment adherence Information, 
motivation or 
behavioural skills 
1 1 1 Remember to cover your mouth when you cough; this prevents TB germs from 
spreading in the air.  
Information /social 
motivation 
 
 4 For a complete cure, you will need to take TB medicines daily for at least 6 months.  Information  
 2 1 Take your TB medicines always at the same time, like when you brush your teeth. 
This will help you remember.  
Skills (maintain 
adherence) 
 
 4 It is normal for TB medicines to cause side effects. Common ones include nausea, 
stomach pains, vomiting, orange urine, joint aches, and skin rash. 
Information  
 3 1 If you have any problems or concerns about your medication, do not stop. Consult 
your TB nurse or doctor. They have tips to help you take your pills.  
Skills (getting 
support) 
 
 4 Keep windows open around you, if possible. Fresh air helps reduce TB germs.  Information / social 
motivation 
 4 1 If you stop taking your medicines or don’t take them correctly, you can pass TB 
germs on to others. 
Information / social 
motivation 
 
 4 Ask a family member or friend to help you remember taking TB medicines.  Skills (getting 
support) 
2 5 1 Do take your TB medicines in full dose, even when you feel good. It is the only way 
to kill TB germs. 
Information/ 
motivation 
 
 4 Adopt a healthy lifestyle. Reduce your chances of ever developing TB again. Motivation 
   Tobacco smoking  
 6 1 Replace smoke with a smile. Replace illness with happiness. Quit today. Motivation 
 
 4 Craving to smoke is temporary but damage to your lungs may be permanent. Information/ 
Motivation 
 7 1 Within 1 month of quitting, you will cough less and breathe easily. Information/ 
Motivation 
 
 4 Alcohol use and smoking will make it harder for your TB to be cured. Information/ 
Motivation 
 8 1 The best way to quit tobacco is to stop immediately. Information/skill 
 
 4 It helps to tell your friends and family “I am ready to quit smoking completely”. Skill (getting  
support) 
3 9 1 After quitting, your body craves for nicotine; this is expected. You may feel 
constipated, irritable, restless, or lightheaded. This will pass. 
Information 
 
  Hazardous and harmful drinking  
 9 4 Alcohol damages your liver and your body’s protection against infection such as 
TB and HIV. 
Information 
 10 1 Cutting down on alcohol will help you recover faster from your TB. Motivation 
 
 4 Heavy alcohol drinking can make people forget to take their TB medication and 
they stay sick longer. 
Motivation/ 
Information 
 11 1 Drinking less saves you money. Think about what extra money could buy you and 
your family. 
Motivation 
 
 4 Stopping drinking alcohol while you are on TB medication is best. But if you do 
drink, drink less. 
Information 
 12 1 It is normal to be nervous when reducing your drinking. It helps to talk to your 
family, friends, or other people to support you. 
Skills (getting 
support) 
 
 4 If you struggle to reduce your drinking, help is at hand. Talk to your nurse or 
another health professional. You are not alone. 
Skills (getting 
support) 
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Table 2. MI Treatment Fidelity of counselling sessions delivered by LHWs (N=22) 
 1st coder  2nd coder  Average both coders 
 Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) 
Global ratings 
Cultivating change 
talk (1-5) 
1.5 (0.7) 1 (1 – 2) 1.5 (0.7) 1 (1 – 2) 1.5 (0.7) 1 (1 – 2) 
Softening sustain 
talk (1-5) 
2.8 (1.0) 3 (2 – 4) 2.1 (1.0) 2 (1 – 3) 2.4 (1.0) 2.5 (1.5 – 3.0) 
Partnership (1-5)  1.8 (0.7) 2 (1 – 2) 1.6 (0.7) 1.5 (1.0 – 2.0) 1.7 (0.7) 2 (1 – 2) 
Empathy (1-5) 2.1 (0.8) 2 (2 – 3) 2.0 (0.8) 2 (1 – 3) 2.1 (0.8) 2 (1 – 3) 
Behavioural counts 
Giving information 0.5 (0.7) 0 (0 – 0) 0.5 (0.8) 0 (0 – 1) 0.5 (0.7) 0 (0 – 1) 
Questions 16.1 (6.8) 13 (11 – 19) 16.4 (7.4) 15 (12 – 21) 16.2 (7.0) 14.5 (11.5 – 
20.0) 
Simple reflection  4.8 (5.3) 3.5 (2.0 – 5.0) 5.0 (5.1) 4.5 (2.0 – 6.0) 4.9 (5.1) 4 (2 – 6) 
Complex reflection 0.3 (0.8) 0 (0 – 0) 0.7 (1.1) 0 (0 – 1) 0.5 (1.0) 0 (0 – 1) 
Affirm  2.3 (1.6) 2.5 (1.0 – 3.0) 2.0 (1.7) 1.5 (1.0 – 3.0) 2.1 (1.6) 2 (1 – 3) 
Emphasize 
Autonomy 
2.4 (2.3) 2 (1 – 3) 2.0 (2.1) 1.5 (1.0 – 3.0) 2.2 (2.2) 2 (1 – 3) 
Seek collaboration 1.0 (1.0) 1 (0 – 2) 1.4 (1.4) 1 (0 – 2) 1.2 (1.2) 1 (0 – 2) 
Persuadea  2.7 (4.9) 1 (0 – 3) 2.2 (4.4) 1 (0 – 2) 2.5 (4.6) 1 (0 – 2.5) 
Confront 0.9 (2.1) 0 (0 – 0) 0.9 (1.9) 0 (0 – 1) 0.9 (2.0) 0 (0 – 1) 
Summary measures 
MI non-Adherent 
persuade+confront  
3.6 (6.3) 2 (0 – 4) 3.1 (5.7) 1 (0 – 3) 3.3 (6.0)  
ICC 0.97b 
1.5 (0.0 – 3.5) 
MI adherent 
collaboration+affirm+ 
emphasizing autonomy 
5.7 (3.7) 5.5 (3.0 – 8.0) 5.3 (3.9) 4.5 (2.0 – 8.0) 5.5 (3.7) 
ICC 0.96b 
5.0 (2.5 – 8.0) 
Technical global 
ratings  
(cultivating change 
talk+softening sustain 
talk)/2 
2.1 (0.8) 2.0 (1.5 – 2.5) 1.8 (0.7) 2 (1 – 2) 2.0 (0.8) 
ICC 0.82b 
2.0 (1.5 – 2.5) 
Relational global 
ratings 
(partnership+empathy)/2 
2.0 (0.7) 2.0 (1.5 – 2.5) 1.8 (0.7) 1.5 (1.0 – 2.5) 1.9 (0.7) 
ICC 0.67b 
2 (1.3 – 2.5) 
Reflection to 
question ratio  
(total reflections/total 
questions) 
0.3 (0.5) 0.2 (0.2-0.4) 0.4 (0.5) 0.2 (0.1-0.6) 0.4 (0.4) 0.2 (0.1-0.4) 
% Complex 
reflection   
[Complex Reflection /(Simple 
3.3% (8.1) - 8.6%(13.5) - 6.0% (11.4) - 
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Reflection+Complex 
Reflection)]*100
 
aPersuade with permission was not assessed as LHWs were not trained specifically in this techniques; bIntraclass 
correlation coefficient  
 
Table 3. TB patients’ experiences and satisfaction with the counselling programme 
and with the counsellor (N=25) 
Variable n (%) 
How would you rate the intervention sessions you attended?   
Very unhelpful 2 (8.0) 
Somewhat unhelpful 0 (0.0) 
Helpful 16 (64.0) 
Somewhat helpful 3 (12.0) 
Very helpful 4 (16.0) 
How much did you enjoy the intervention sessions?  
Not at all 0 (0.0) 
A little 0 (0.0) 
Quite a lot 4 (16.0) 
Very much 10 (40.0) 
A great deal 11 (44.0) 
Self-reported changes in knowledge, behaviour and health/emotional 
status as a result of the intervention (yes/no for each question, N=24)  
 
I drink less alcohol now 13 (54.2) 
I smoke less cigarettes now 12 (50.0)a 
I use drugs less now 0 (0.0) 
I quit smoking cigarettes 8 (32.0)a 
I know more about tobacco’s negative effects 16 (66.7) 
I know more about alcohol’s negative effects 16 (66.7) 
I learned a skill I can use 12 (50.0) 
I am more adherent to my TB medication 23 (95.8) 
I am more adherent to my ART 12 (50.0) 
I feel in a better emotional health 21 (87.5) 
I feel in a better physical health 19 (79.2) 
I started ART as a result of the intervention 8 (33.3) 
These sessions did not benefit me in any way 0 (0.0) 
Other people would benefit from attending these sessions 11 (44.0) 
How much did you like the counsellor’s style of interacting with you?   
Not at all 0 (0.0) 
A little 0 (0.0) 
Quite a lot 3 (12.0) 
Very much 4 (16.0) 
A great deal 18 (72.0) 
Which of the following describes your counsellor? (prompted)  
Knowledgeable 24 (96.0) 
Kind 24 (96.0) 
Directive 23 (92.0) 
Judgemental 1 (4.0) 
Helpful 24 (96.0) 
Non-judgemental 20 (80.0) 
Easy-going 23 (92.0) 
Gentle 18 (72.0) 
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Trustworthy 24 (96.0) 
Good listener 23 (92.0) 
Warm 24 (96.0) 
Cold 0 (0.0) 
Scolding 0 (0.0) 
Other (loving, caring and polite) 3 (12.0) 
aThere were 19 current smokers among the respondents, therefore 8/19 or 42.1% of current smokers reported 
having quit and 12/19 or 63.2 reported having reduced cigarette smoking  
 
Table 4. TB patients’ experience and satisfaction with the SMS-programme (N=25) 
Variable n (%) 
Reported not having received any messages 2 (8.0) 
Perceived helpfulness of this aspect of the intervention  
Very helpful 8 (32.0) 
Somewhat helpful 2 (8.0) 
Helpful 6 (24.0) 
Somewhat unhelpful 1 (4.0) 
Very unhelpful 8 (32.0) 
Perceived length of messages  
Far too long 3 (12.0) 
A bit too long 1 (4.0) 
The right length 17 (68.0) 
A bit too short 3 (12.0) 
Far too short 1 (4.0) 
Perceived frequency   
Far too frequently 3 (12.0) 
A bit too frequently 0 (0.0) 
Frequently enough 17 (68.0) 
A bit too infrequently 3 (12.0) 
Far too infrequently 2 (8.0) 
Messages were easy to understand  
No 17 (68.0) 
Yes 8 (32.0) 
Perceived duration of receiving the messages   
Should have lasted much longer 8 (32.0) 
Should have lasted a bit longer 15 (60.0) 
Just right 0 (0.0) 
Should have been stopped a bit earlier 0 (0.0) 
Should have been stopped much earlier 2 (8.0) 
Perceived discomfort if other people had seen the messages   
Extremely comfortable 4 (16.0) 
Very comfortable 8 (32.0) 
Comfortable 10 (40.0) 
A bit uncomfortable 3 (12.0) 
Very uncomfortable 0 (0.0) 
Understanding of the languages used in the messages   
Very easy to understand/ 9 (36.0) 
Somewhat easy to understand 1 (4.0) 
Easy to understand 13 (52.0) 
Somewhat difficult to understand 2 (8.0) 
Very difficult to understand 0 (0.0) 
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